187 related articles for article (PubMed ID: 35241692)
1. Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations.
Yehia L; Ni Y; Sadler T; Frazier TW; Eng C
NPJ Genom Med; 2022 Mar; 7(1):16. PubMed ID: 35241692
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial genome as a modifier of autism versus cancer phenotypes in
Wei R; Yehia L; Ni Y; Eng C
HGG Adv; 2023 Jul; 4(3):100199. PubMed ID: 37216009
[TBL] [Abstract][Full Text] [Related]
3. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
[TBL] [Abstract][Full Text] [Related]
4. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
5. Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer.
Smith IN; Thacker S; Seyfi M; Cheng F; Eng C
Am J Hum Genet; 2019 May; 104(5):861-878. PubMed ID: 31006514
[TBL] [Abstract][Full Text] [Related]
6. Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome.
Yehia L; Ni Y; Feng F; Seyfi M; Sadler T; Frazier TW; Eng C
Am J Hum Genet; 2019 Oct; 105(4):813-821. PubMed ID: 31564436
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral change.
Busch RM; Frazier Ii TW; Sonneborn C; Hogue O; Klaas P; Srivastava S; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
J Neurodev Disord; 2023 Jan; 15(1):3. PubMed ID: 36641436
[TBL] [Abstract][Full Text] [Related]
8. Differential cell cycle checkpoint evasion by PTEN germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.
Hitomi M; Venegas J; Kang SC; Eng C
Oncogene; 2023 Dec; 42(50):3698-3707. PubMed ID: 37907589
[TBL] [Abstract][Full Text] [Related]
9. PTEN Hamartoma tumor syndrome in childhood: A review of the clinical literature.
Macken WL; Tischkowitz M; Lachlan KL
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):591-610. PubMed ID: 31609537
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and psychological features of PTEN mutations: a systematic review of the literature and meta-analysis of the prevalence of autism spectrum disorder characteristics.
Cummings K; Watkins A; Jones C; Dias R; Welham A
J Neurodev Disord; 2022 Jan; 14(1):1. PubMed ID: 34983360
[TBL] [Abstract][Full Text] [Related]
11. Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production.
Tilot AK; Gaugler MK; Yu Q; Romigh T; Yu W; Miller RH; Frazier TW; Eng C
Hum Mol Genet; 2014 Jun; 23(12):3212-27. PubMed ID: 24470394
[TBL] [Abstract][Full Text] [Related]
12. Case Series: Neurobehavioral Profile of Adolescents with PTEN Hamartoma Tumor Syndrome.
Hasler HM; Murray A; Canavera KE; Parris KR; Nichols KE; Jacola LM
J Pediatr Neuropsychol; 2022 Jun; 8(2):79-85. PubMed ID: 37090027
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing between PTEN clinical phenotypes through mutation analysis.
Portelli S; Barr L; de Sá AGC; Pires DEV; Ascher DB
Comput Struct Biotechnol J; 2021; 19():3097-3109. PubMed ID: 34141133
[TBL] [Abstract][Full Text] [Related]
14. Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome.
Brewer T; Yehia L; Bazeley P; Eng C
NPJ Genom Med; 2023 Jul; 8(1):14. PubMed ID: 37407629
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
[TBL] [Abstract][Full Text] [Related]
16. 65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes:
Yehia L; Eng C
Endocr Relat Cancer; 2018 Aug; 25(8):T121-T140. PubMed ID: 29792313
[TBL] [Abstract][Full Text] [Related]
17. Genomic diversity in functionally relevant genes modifies neurodevelopmental versus neoplastic risks in individuals with germline PTEN variants.
Eng C; Kim A; Yehia L
Res Sq; 2023 Dec; ():. PubMed ID: 38168271
[TBL] [Abstract][Full Text] [Related]
18. Brain morphological analysis in PTEN hamartoma tumor syndrome.
Shiohama T; Levman J; Vasung L; Takahashi E
Am J Med Genet A; 2020 May; 182(5):1117-1129. PubMed ID: 32162846
[TBL] [Abstract][Full Text] [Related]
19. Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephaly.
Wong CW; Or PMY; Wang Y; Li L; Li J; Yan M; Cao Y; Luk HM; Tong TMF; Leslie NR; Lo IF; Choy KW; Chan AML
Autism Res; 2018 Aug; 11(8):1098-1109. PubMed ID: 29608813
[TBL] [Abstract][Full Text] [Related]
20. Germline PTEN genotype-dependent phenotypic divergence during the early neural developmental process of forebrain organoids.
Kang SC; Sarn NB; Venegas J; Tan Z; Hitomi M; Eng C
Mol Psychiatry; 2023 Nov; ():. PubMed ID: 38030818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
